|
|
|
 |
|
|
 |
|
|
| |
 |
| |
 |
| |
| |
 |
| Coelacanth Chemical Corporation (LEXG) |
OBP II |
(Acquired by Lexicon Genetics Inc)
The Woodlands, TX
www.lexicon-genetics.com
Coelacanth, which uses proprietary chemistry technologies and knockout mice to rapidly
discover new chemical entities for drug development, recently merged with
Lexicon Genetics and will form the core for a new division called Lexicon
Pharmaceuticals, based in Princeton, N.J. Lexicon Pharmaceuticals will combine
Lexicon's novel, functionally defined targets from the human genome with Coelacanth
Corporation's high performance chemistry technologies to discover new drugs.
|
|
| |
|
|
|
|
|
